U.S. Pharmaceuticals & Biotech Most Popular Stocks

Marker Therapeutics

Market Cap: US$11.4m

A clinical-stage immuno-oncology company, engages in the development and commercialization of novel T cell-based immunotherapies for the treatment of hematological malignancies and solid tumor indications.

HOOKIPA Pharma

Market Cap: US$11.3m

A clinical stage biopharmaceutical company, develops immunetherapeutics targeting infectious diseases based on its proprietary arenavirus platform.

Carisma Therapeutics

Market Cap: US$11.2m

A biotechnology company, focuses on developing transformative therapies to treat liver fibrosis and cancer in the United States.

Artelo Biosciences

Market Cap: US$11.2m

A clinical stage biopharmaceutical company, develops and commercializes therapeutics that target lipid-signaling pathways in the United States.

Zenith Capital

Market Cap: US$11.2m

A biotechnology investment company, engages in the development of bromodomain inhibitors for the treatment of cancer and other disorders with unmet medical needs.

Quantumzyme

Market Cap: US$11.1m

Operates as a biotransformation company.

Sensei Biotherapeutics

Market Cap: US$11.1m

A clinical-stage biotechnology company, engages in the discovery and development of therapeutics for cancer patients.

Eco-Growth Strategies

Market Cap: US$10.8m

Falcon Technologies, Inc. provides various design-build infrastructure services.

Bolt Biotherapeutics

Market Cap: US$10.6m

A clinical-stage biopharmaceutical company, engages in the development of immunotherapies for the treatment of cancer.

Bio Green Med Solution

Market Cap: US$10.6m

Engages in the distributing, trading, and installation of protective and fire safety materials and equipment, and fire protection and prevention systems.

Lyra Therapeutics

Market Cap: US$10.5m

A clinical-stage biotechnology company, focuses on the development and commercialization of anti-inflammatory therapies for the treatment of patients with chronic rhinosinusitis.

Evoke Pharma

Market Cap: US$10.5m

Operates as a specialty pharmaceutical company that focuses on the development and commercialization of drugs for the treatment of gastroenterological disorders and diseases.

Matinas BioPharma Holdings

Market Cap: US$10.4m

A clinical-stage biopharmaceutical company, identifies and develops pharmaceutical products using its lipid nanocrystal (LNC) platform technology.

Ludwig Enterprises

Market Cap: US$10.3m

Operates as a genomic technology and health related company in the United States.

Biofrontera

Market Cap: US$10.2m

A biopharmaceutical company, engages in the commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States.

EOM Pharmaceuticals Holdings

Market Cap: US$10.1m

Immunocellular Therapeutics, Ltd., a clinical-stage pharmaceutical company, focuses on the development of therapeutics and delivery technologies for the treatment of inflammatory conditions and ocular diseases.

KRTL Holding Group

Market Cap: US$9.9m

KRTL Holding Group, Inc, a beverage and food company, engages in the production and distribution of bottled natural spring water and flavored carbonated water in North America and internationally.

BetterLife Pharma

Market Cap: US$9.9m

A biotechnology company, primarily focuses on developing compounds for the treatment of mental disorders in Canada.

Inhibitor Therapeutics

Market Cap: US$9.8m

A pharmaceutical development company, develops and commercializes therapeutics for patients with certain cancers and non-cancerous proliferation disorders in the United States.

Dogwood Therapeutics

Market Cap: US$9.8m

A development-stage biotechnology company, focuses on the development of medicine to treat pain and fatigue-related disorders.

Processa Pharmaceuticals

Market Cap: US$9.7m

A clinical stage biopharmaceutical company, develops chemotherapy drugs to improve the safety and efficacy of cancer treatment.

IN8bio

Market Cap: US$9.5m

A clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of gamma-delta T cell product candidates for the treatment of cancer and autoimmune diseases.

ESSA Pharma

Market Cap: US$9.5m

A clinical stage pharmaceutical company, focuses the development of small molecule drugs for the treatment of prostate cancer.

Qualigen Therapeutics

Market Cap: US$9.4m

A clinical-stage therapeutics company, focuses on the development of treatments for adult and pediatric cancer.

IM Cannabis

Market Cap: US$9.3m

Engages in breeding, growing, and supply of medical cannabis products in Israel and Germany.

AEON Biopharma

Market Cap: US$9.1m

A clinical stage biopharmaceutical company, focuses on developing botulinum toxins.

Lotus Pharmaceuticals

Market Cap: US$9.0m

Does not have significant operations.

VivoSim Labs

Market Cap: US$9.0m

A pharmaceutical and biotechnology services company, provides testing of drugs and drug candidates in three-dimensional (3D) human tissue models of liver and intestine.

Kiora Pharmaceuticals

Market Cap: US$8.8m

A clinical-stage specialty pharmaceutical company, engages in the development and commercialization of therapies for the treatment of ophthalmic diseases.

HCW Biologics

Market Cap: US$8.8m

A clinical-stage biopharmaceutical company, focuses on discovering and developing novel immunotherapies for chronic, low-grade inflammation, and age-related diseases in the United States.

Cyclerion Therapeutics

Market Cap: US$8.7m

A biopharmaceutical company, develops treatments for serious diseases serious diseases with novel sGC stimulators in both the central nervous system (CNS) and the periphery.

Curative Biotechnology

Market Cap: US$8.6m

A development-stage biomedical company, develops, licenses, and commercializes pharmaceutical products and medical devices for patients with rare diseases.

Ernexa Therapeutics

Market Cap: US$8.6m

A preclinical-stage company, develops induces derived mesenchymal stem cells (iMSC) therapies for the treatment of solid tumors and autoimmune disease.

America Great Health

Market Cap: US$8.5m

Operates as a biotechnology company in the United States.

Aprea Therapeutics

Market Cap: US$8.4m

A clinical-stage biopharmaceutical company, focuses on developing and commercializing novel synthetic lethality-based cancer therapeutics that targets DNA damage response pathways.

Creative Medical Technology Holdings

Market Cap: US$8.4m

A commercial-stage biotechnology company, focuses on novel biological therapeutics in the fields of immunotherapy, endocrinology, urology, neurology, and orthopedics in the United States.